Logistic Regression Analysis to Identify Clinical Factors Contributing to Presence of DD2–3 in HFpEF Patients
| Univariate | Multivariate model 1 | Multivariate model 2 | ||||
| Factor | OR | P | OR | P | OR | P |
| Age (per 10 y) | 0.92 (0.59–1.43) | 0.72 | – | – | – | – |
| Sex (male) | 1.94 (0.53–7.77) | 0.32 | – | – | – | – |
| BMI (kg/m2) | 0.99 (0.86–1.13) | 0.88 | – | – | – | – |
| Hypertension | 0.21 (0.05–0.79) | 0.02 | 0.29 (0.06–1.37) | 0.12 | 0.18 (0.03–0.98) | 0.048 |
| Diabetes | 0.43 (0.11–1.56) | 0.20 | – | – | – | – |
| Coronary artery disease | 1.56 (0.41–6.03) | 0.51 | – | – | 3.41 (0.59–25.2) | 0.17 |
| Atrial fibrillation | 1.02 (0.28–3.68) | 0.97 | – | – | – | – |
| B-type natriuretic peptide (per 100 pg/mL) | 1.19 (0.87–1.81) | 0.29 | – | – | – | – |
| SHFM mean life expectancy (y) | 0.95 (0.81–1.10) | 0.49 | – | – | – | – |
| LVEF (per 5%) | 0.76 (0.51–1.08) | 0.13 | 1.04 (0.60–1.83) | 0.89 | 1.08 (0.60–2.05) | 0.80 |
| LV mass index (per 10 g/m2) | 1.08 (0.90–1.32) | 0.39 | – | – | – | – |
| Global RI (per 0.01 min−1) | 0.64 (0.41–0.90) | 0.008 | 0.66 (0.38–0.99) | 0.044 | 0.62 (0.33–0.98) | 0.042 |
| CVRI (per 5%) | 1.76 (1.06–3.20) | 0.03 | 1.88 (1.01–3.95) | 0.046 | 1.79 (0.94–3.88) | 0.08 |
OR = odds ratio; model 1 = including LVEF and stepwise-selected variables; model 2 = including coronary artery disease, LVEF, and stepwise-selected variables; BMI = body mass index.
Data in parentheses are 95% confidence intervals.